The Atrial High Rate Episodes in Pacemaker Patients
1 other identifier
observational
427
3 countries
42
Brief Summary
Prospective study assessing the incidence of atrial high rate episodes (AHRE) in pacemaker patients with and without previously diagnosed AT.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2000
Longer than P75 for all trials
42 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2000
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2004
CompletedFirst Submitted
Initial submission to the registry
December 26, 2007
CompletedFirst Posted
Study publicly available on registry
March 3, 2008
CompletedMarch 3, 2008
February 1, 2008
December 26, 2007
February 22, 2008
Conditions
Keywords
Study Arms (2)
1
pacemaker patients with previously diagnosed AT.
2
pacemaker patients without previously diagnosed AT.
Eligibility Criteria
Prospective study with patients undergoing a Medtronic Kappa DR 700 or Medtronic Kappa 900 DR implant, for approved indications.
You may qualify if:
- Patients undergoing a Medtronic Kappa DR 700 or Medtronic Kappa 900 DR implant, for approved indications
- No previous history of pacemaker implantation
- Patients 50 years of age or older
You may not qualify if:
- Patients with a history of atrial tachyarrhythmias (primary arm of study)
- Patients with medical conditions that would limit study participation
- Patients inaccessible for follow-up at the study center
- Patients incapable of providing Informed Consent
- Patients with NYHA classification of IV
- Patients with a history of neurocardiogenic syncope, long QT syndrome, or Hypertrophic Obstructive Cardiomyopathy (HOCM)
- Patients taking Sotalol or Amiodorone
- Patients with a history of a prior ICD or pacemaker implantation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (42)
Unknown Facility
Hot Springs, Arkansas, United States
Unknown Facility
Little Rock, Arkansas, United States
Unknown Facility
Fresno, California, United States
Unknown Facility
Glendale, California, United States
Unknown Facility
San Diego, California, United States
Unknown Facility
Daytona Beach, Florida, United States
Unknown Facility
Orlando, Florida, United States
Unknown Facility
Hammond, Indiana, United States
Unknown Facility
Hobart, Indiana, United States
Unknown Facility
Munster, Indiana, United States
Unknown Facility
Louisville, Kentucky, United States
Unknown Facility
Marrero, Louisiana, United States
Unknown Facility
Shreveport, Louisiana, United States
Unknown Facility
Salisbury, Maryland, United States
Unknown Facility
West Roxbury, Massachusetts, United States
Unknown Facility
Saint Cloud, Minnesota, United States
Unknown Facility
Livingston, New Jersey, United States
Unknown Facility
Patterson, New Jersey, United States
Unknown Facility
Flushing, New York, United States
Unknown Facility
Rochester, New York, United States
Unknown Facility
Syracuse, New York, United States
Unknown Facility
The Bronx, New York, United States
Unknown Facility
Charlotte, North Carolina, United States
Unknown Facility
Gastonia, North Carolina, United States
Unknown Facility
Greenville, North Carolina, United States
Unknown Facility
Willimington, North Carolina, United States
Unknown Facility
Oklahoma City, Oklahoma, United States
Unknown Facility
Bethlehem, Pennsylvania, United States
Unknown Facility
Mechanicsburg, Pennsylvania, United States
Unknown Facility
Scranton, Pennsylvania, United States
Unknown Facility
Wynnewood, Pennsylvania, United States
Unknown Facility
Providence, Rhode Island, United States
Unknown Facility
Chattanooga, Tennessee, United States
Unknown Facility
Dallas, Texas, United States
Unknown Facility
Falls Church, Virginia, United States
Unknown Facility
Richmond, Virginia, United States
Unknown Facility
Milwaukee, Wisconsin, United States
Unknown Facility
Ashford, Australia
Unknown Facility
Ballarat, Australia
Unknown Facility
Bedford Park, Australia
Unknown Facility
Lille, France
Unknown Facility
Rouen, France
Related Publications (2)
Ghali JK, Orlov MV, Araghi-Niknam M, Sherfesee L, Hettrick DA. The influence of symptoms and device detected atrial tachyarrhythmias on medical management: insights from A-HIRATE. Pacing Clin Electrophysiol. 2007 Jul;30(7):850-7. doi: 10.1111/j.1540-8159.2007.00772.x.
PMID: 17584266BACKGROUNDOrlov MV, Ghali JK, Araghi-Niknam M, Sherfesee L, Sahr D, Hettrick DA; Atrial High Rate Trial Investigators. Asymptomatic atrial fibrillation in pacemaker recipients: incidence, progression, and determinants based on the atrial high rate trial. Pacing Clin Electrophysiol. 2007 Mar;30(3):404-11. doi: 10.1111/j.1540-8159.2007.00682.x.
PMID: 17367361RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
M. V. Orlov, MD
Tufts University School of Medicine
- PRINCIPAL INVESTIGATOR
J.K. Ghali, MD
Louisiana State University Health Sciences Center in New Orleans
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
December 26, 2007
First Posted
March 3, 2008
Study Start
July 1, 2000
Study Completion
September 1, 2004
Last Updated
March 3, 2008
Record last verified: 2008-02